Abstract 401
Case Summary
68/F, Filipino, diagnosed with ovarian CA stIV (lung) 1992, s/p TAHBSO, s/p platinum-based chemotherapy, on surveillance.
In 2012, had painless hematuria. Referred to a nephrologist. Urinalysis done showed large hematuria, few WBCs, treated as UTI, with resolution of hematuria while on antibiotic therapy, but with recurrence after. All other workups/imaging (UTZ, CT scan) normal.
August 2012, screening mammogram done showed breast mass, R (IDCA stIIB, ER+ PR- HER2-), s/p MRM, s/p 6 cycles Paclitaxel Carboplatin, with resolution of hematuria while on treatment.
January 2013, chemo completed, started on Letrozole. Recurrence of hematuria. All workups/imaging normal.
May 2013, still with hematuria. CT scan showed L hydronephrosis and L hydroureter, may be secondary to a previous passage of stone or distal ureteral stricture. No discrete mass or intraluminal filling defects noted. Advised observation.
June 2013, still with hematuria. Treated as UTI, with resolution of hematuria while on antibiotic therapy, but with recurrence after. All other workups/imaging/cystoscopy with biopsy normal.
November 2013, still with hematuria. CT scan showed an ill-defined soft tissue density at upper pole of L kidney with involvement of both calyx and parenchyma, measuring 2.3 x 2.9 x 2.2 cm, with mild dilatation of distal L ureter, with ill-defined nodule measuring 0.9 x 0.9 cm adjacent to the distal segment which could be a prominent-sized lymph node.
December 2013, s/p Radical nephrectomy L. Histopath showed Invasive papillary urothelial carcinoma, high grade, pelvis, tumor size 3.7 cm in single widest diameter, with invasion to the lamina propria of the pelvis and into the renal parenchyma, with lymphovascular invasion, ureteral margins, perinephric fat and major renal vessels, negative for tumor. Final diagnosis is Invasive papillary urothelial carcinoma, L renal pelvis, StIII (pT3N0M0), s/p 6 cycles Gemcitabine Carboplatin.
Past medical history unremarkable, nonsmoker, no alcohol intake, no exposure to chemicals, G0 with surgical menopause 48 yo, with family history of rhabdomyosarcoma (father) and breast cancer (sister).
BRCA mutation testing done, negative.
Currently, patient is 73 years old, asymptomatic, on surveillance.
Editorial acknowledgement
Clinical trial identification
Resources from the same session
750 - HER2 positive rates in Invasive Lobular Breast Carcinoma : A study amongst 1,095 consecutive Asian patients
Presenter: Ga Jing Kee
Session: Poster display - Cocktail
Resources:
Abstract
1417 - CanAssist-breast -an immunohistochemistry based test for risk of recurrence prediction for early stage breast cancer patients: a cost-effective and accurate solution for Asia
Presenter: Manjiri Bakre
Session: Poster display - Cocktail
Resources:
Abstract
1468 - Topical silymarin administration for prevention of radiodermatitis in breast cancer patients: a randomized, double-blind, placebo-controlled clinical trial
Presenter: Sepideh Elyasi
Session: Poster display - Cocktail
Resources:
Abstract
873 - Comparison of interstitial brachytherapy with volumetric modulated arc therapy for tumour bed boost following breast conservative surgery
Presenter: Kannan Periasamy
Session: Poster display - Cocktail
Resources:
Abstract
1140 - Triple Negative Breast Cancer and Platinum-based Systemic Treatment: Meta-analysis and Systematic Review
Presenter: Jessa Gilda Pandy
Session: Poster display - Cocktail
Resources:
Abstract
168 - Longitudinal study on incidences of obesity and weight changes in Chinese patients with early-stage breast cancer
Presenter: Winnie Yeo
Session: Poster display - Cocktail
Resources:
Abstract
311 - Effect of combined CYP2C19 and CYP2D6 genotype on tamoxifen treatment outcome in breast cancer indicates endogenous and exogenous interplay
Presenter: Hanjing Xie
Session: Poster display - Cocktail
Resources:
Abstract
669 - A novel nipple aleolar complex involvement predictive index (NACPI) for indicating nipple sparing mastectomy in breast cancer
Presenter: Hirohito Seki
Session: Poster display - Cocktail
Resources:
Abstract
938 - Multicenter Trial for Safety and Toxicity of Nanoxel®M in Breast Cancer
Presenter: Tae Hyun Kim
Session: Poster display - Cocktail
Resources:
Abstract
1129 - Implication of PET-CT to improve negative predictive value for axillary lymph node metastasis in early breast cancer
Presenter: Oyeon Cho
Session: Poster display - Cocktail
Resources:
Abstract